nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0413	0.121	CbGbCtD
Vinorelbine—CYP3A4—Calcitriol—osteoporosis	0.0384	0.113	CbGbCtD
Vinorelbine—CYP3A4—Estropipate—osteoporosis	0.0384	0.113	CbGbCtD
Vinorelbine—CYP2D6—Cholecalciferol—osteoporosis	0.0311	0.0912	CbGbCtD
Vinorelbine—CYP3A4—Ergocalciferol—osteoporosis	0.0307	0.09	CbGbCtD
Vinorelbine—ABCB1—Conjugated Estrogens—osteoporosis	0.0303	0.0889	CbGbCtD
Vinorelbine—ABCB1—Estradiol—osteoporosis	0.0266	0.078	CbGbCtD
Vinorelbine—CYP3A4—Raloxifene—osteoporosis	0.0256	0.0751	CbGbCtD
Vinorelbine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0247	0.0725	CbGbCtD
Vinorelbine—CYP3A4—Cholecalciferol—osteoporosis	0.0198	0.058	CbGbCtD
Vinorelbine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0182	0.0532	CbGbCtD
Vinorelbine—CYP3A4—Estradiol—osteoporosis	0.0159	0.0467	CbGbCtD
Vinorelbine—TUBB6—Fulvestrant—Estradiol—osteoporosis	0.00238	0.602	CbGdCrCtD
Vinorelbine—TUBB1—Protein folding—TUBA1B—osteoporosis	0.0018	0.00598	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.0018	0.00598	CbGpPWpGaD
Vinorelbine—TUBB4A—Chaperonin-mediated protein folding—TUBA1B—osteoporosis	0.00177	0.00589	CbGpPWpGaD
Vinorelbine—TUBB4B—Protein folding—CCT2—osteoporosis	0.00174	0.00577	CbGpPWpGaD
Vinorelbine—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00162	0.00539	CbGpPWpGaD
Vinorelbine—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00162	0.00539	CbGpPWpGaD
Vinorelbine—TUBB4B—Chaperonin-mediated protein folding—TUBA1B—osteoporosis	0.00162	0.00539	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.00162	0.00537	CbGpPWpGaD
Vinorelbine—TUBB4A—Protein folding—TUBA1B—osteoporosis	0.00162	0.00537	CbGpPWpGaD
Vinorelbine—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00161	0.00534	CbGpPWpGaD
Vinorelbine—TUBB6—Levorphanol—Estradiol—osteoporosis	0.00157	0.398	CbGdCrCtD
Vinorelbine—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00157	0.00521	CbGpPWpGaD
Vinorelbine—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00152	0.00504	CbGpPWpGaD
Vinorelbine—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00149	0.00493	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.00148	0.00491	CbGpPWpGaD
Vinorelbine—TUBB4B—Protein folding—TUBA1B—osteoporosis	0.00148	0.00491	CbGpPWpGaD
Vinorelbine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00145	0.00482	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00137	0.00453	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00137	0.00453	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00135	0.00449	CbGpPWpGaD
Vinorelbine—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00133	0.00443	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00132	0.00438	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00128	0.00424	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00125	0.00414	CbGpPWpGaD
Vinorelbine—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00122	0.00405	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00112	0.00372	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00103	0.0034	CbGpPWpGaD
Vinorelbine—TUBB2B—Orphan transporters—ANXA2—osteoporosis	0.000965	0.0032	CbGpPWpGaD
Vinorelbine—TUBB6—Orphan transporters—ANXA2—osteoporosis	0.000965	0.0032	CbGpPWpGaD
Vinorelbine—TUBB3—Orphan transporters—ANXA2—osteoporosis	0.000932	0.00309	CbGpPWpGaD
Vinorelbine—TUBB2A—Orphan transporters—ANXA2—osteoporosis	0.000903	0.00299	CbGpPWpGaD
Vinorelbine—TUBB1—Orphan transporters—ANXA2—osteoporosis	0.000883	0.00293	CbGpPWpGaD
Vinorelbine—TUBB4A—Orphan transporters—ANXA2—osteoporosis	0.000792	0.00263	CbGpPWpGaD
Vinorelbine—TUBB4B—Orphan transporters—ANXA2—osteoporosis	0.000725	0.0024	CbGpPWpGaD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000619	0.00205	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000482	0.0016	CbGpPWpGaD
Vinorelbine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000376	0.00125	CbGpPWpGaD
Vinorelbine—Leukopenia—Zoledronate—osteoporosis	0.000341	0.000964	CcSEcCtD
Vinorelbine—Anaphylactic shock—Pamidronate—osteoporosis	0.00034	0.000962	CcSEcCtD
Vinorelbine—Infection—Pamidronate—osteoporosis	0.000338	0.000956	CcSEcCtD
Vinorelbine—Urticaria—Calcitriol—osteoporosis	0.000338	0.000955	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000337	0.00112	CbGpPWpGaD
Vinorelbine—Palpitations—Zoledronate—osteoporosis	0.000337	0.000951	CcSEcCtD
Vinorelbine—Abdominal pain—Calcitriol—osteoporosis	0.000336	0.00095	CcSEcCtD
Vinorelbine—Body temperature increased—Calcitriol—osteoporosis	0.000336	0.00095	CcSEcCtD
Vinorelbine—Hypoaesthesia—Estradiol—osteoporosis	0.000335	0.000948	CcSEcCtD
Vinorelbine—Angioedema—Conjugated Estrogens—osteoporosis	0.000335	0.000947	CcSEcCtD
Vinorelbine—Hypersensitivity—Estropipate—osteoporosis	0.000334	0.000943	CcSEcCtD
Vinorelbine—Nervous system disorder—Pamidronate—osteoporosis	0.000334	0.000943	CcSEcCtD
Vinorelbine—Thrombocytopenia—Pamidronate—osteoporosis	0.000333	0.000942	CcSEcCtD
Vinorelbine—Vomiting—Etidronic acid—osteoporosis	0.000333	0.000941	CcSEcCtD
Vinorelbine—Cough—Zoledronate—osteoporosis	0.000332	0.00094	CcSEcCtD
Vinorelbine—Tachycardia—Pamidronate—osteoporosis	0.000332	0.000939	CcSEcCtD
Vinorelbine—Connective tissue disorder—Estradiol—osteoporosis	0.000331	0.000937	CcSEcCtD
Vinorelbine—Rash—Etidronic acid—osteoporosis	0.00033	0.000933	CcSEcCtD
Vinorelbine—Dermatitis—Etidronic acid—osteoporosis	0.00033	0.000932	CcSEcCtD
Vinorelbine—Vertigo—Conjugated Estrogens—osteoporosis	0.000329	0.000931	CcSEcCtD
Vinorelbine—Hypertension—Zoledronate—osteoporosis	0.000329	0.00093	CcSEcCtD
Vinorelbine—Hypersensitivity—Alendronate—osteoporosis	0.000329	0.000929	CcSEcCtD
Vinorelbine—Headache—Etidronic acid—osteoporosis	0.000328	0.000927	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000326	0.000922	CcSEcCtD
Vinorelbine—Asthenia—Estropipate—osteoporosis	0.000325	0.000919	CcSEcCtD
Vinorelbine—Anorexia—Pamidronate—osteoporosis	0.000324	0.000917	CcSEcCtD
Vinorelbine—Myalgia—Zoledronate—osteoporosis	0.000324	0.000917	CcSEcCtD
Vinorelbine—Arthralgia—Zoledronate—osteoporosis	0.000324	0.000917	CcSEcCtD
Vinorelbine—Chest pain—Zoledronate—osteoporosis	0.000324	0.000917	CcSEcCtD
Vinorelbine—Palpitations—Conjugated Estrogens—osteoporosis	0.000324	0.000916	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000322	0.00091	CcSEcCtD
Vinorelbine—Paraesthesia—Risedronate—osteoporosis	0.000321	0.000909	CcSEcCtD
Vinorelbine—Pruritus—Estropipate—osteoporosis	0.00032	0.000906	CcSEcCtD
Vinorelbine—Discomfort—Zoledronate—osteoporosis	0.00032	0.000906	CcSEcCtD
Vinorelbine—Asthenia—Alendronate—osteoporosis	0.00032	0.000905	CcSEcCtD
Vinorelbine—Hypersensitivity—Ibandronate—osteoporosis	0.00032	0.000905	CcSEcCtD
Vinorelbine—Cough—Conjugated Estrogens—osteoporosis	0.00032	0.000905	CcSEcCtD
Vinorelbine—Dyspnoea—Risedronate—osteoporosis	0.000319	0.000902	CcSEcCtD
Vinorelbine—Hypotension—Pamidronate—osteoporosis	0.000318	0.000899	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000317	0.000896	CcSEcCtD
Vinorelbine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000317	0.000895	CcSEcCtD
Vinorelbine—Pruritus—Alendronate—osteoporosis	0.000316	0.000892	CcSEcCtD
Vinorelbine—Constipation—Ethinyl Estradiol—osteoporosis	0.000314	0.000888	CcSEcCtD
Vinorelbine—Hypersensitivity—Calcitriol—osteoporosis	0.000313	0.000886	CcSEcCtD
Vinorelbine—Flushing—Estradiol—osteoporosis	0.000313	0.000885	CcSEcCtD
Vinorelbine—Cardiac disorder—Estradiol—osteoporosis	0.000313	0.000885	CcSEcCtD
Vinorelbine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000312	0.000883	CcSEcCtD
Vinorelbine—Myalgia—Conjugated Estrogens—osteoporosis	0.000312	0.000883	CcSEcCtD
Vinorelbine—Chest pain—Conjugated Estrogens—osteoporosis	0.000312	0.000883	CcSEcCtD
Vinorelbine—Asthenia—Ibandronate—osteoporosis	0.000312	0.000881	CcSEcCtD
Vinorelbine—Nausea—Etidronic acid—osteoporosis	0.000311	0.000879	CcSEcCtD
Vinorelbine—Anaphylactic shock—Zoledronate—osteoporosis	0.000311	0.000879	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00031	0.000877	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00031	0.000876	CcSEcCtD
Vinorelbine—Diarrhoea—Estropipate—osteoporosis	0.00031	0.000876	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000309	0.000874	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—CCT2—osteoporosis	0.000309	0.00102	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CCT2—osteoporosis	0.000309	0.00102	CbGpPWpGaD
Vinorelbine—Infection—Zoledronate—osteoporosis	0.000309	0.000873	CcSEcCtD
Vinorelbine—Fatigue—Risedronate—osteoporosis	0.000309	0.000872	CcSEcCtD
Vinorelbine—Pruritus—Ibandronate—osteoporosis	0.000307	0.000869	CcSEcCtD
Vinorelbine—Constipation—Risedronate—osteoporosis	0.000306	0.000865	CcSEcCtD
Vinorelbine—Pain—Risedronate—osteoporosis	0.000306	0.000865	CcSEcCtD
Vinorelbine—Angiopathy—Estradiol—osteoporosis	0.000306	0.000865	CcSEcCtD
Vinorelbine—Paraesthesia—Pamidronate—osteoporosis	0.000306	0.000864	CcSEcCtD
Vinorelbine—Diarrhoea—Alendronate—osteoporosis	0.000305	0.000863	CcSEcCtD
Vinorelbine—Asthenia—Calcitriol—osteoporosis	0.000305	0.000862	CcSEcCtD
Vinorelbine—Nervous system disorder—Zoledronate—osteoporosis	0.000305	0.000862	CcSEcCtD
Vinorelbine—Immune system disorder—Estradiol—osteoporosis	0.000305	0.000861	CcSEcCtD
Vinorelbine—Thrombocytopenia—Zoledronate—osteoporosis	0.000304	0.00086	CcSEcCtD
Vinorelbine—Mediastinal disorder—Estradiol—osteoporosis	0.000304	0.000859	CcSEcCtD
Vinorelbine—Dyspnoea—Pamidronate—osteoporosis	0.000303	0.000858	CcSEcCtD
Vinorelbine—Tachycardia—Zoledronate—osteoporosis	0.000303	0.000858	CcSEcCtD
Vinorelbine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000303	0.000855	CcSEcCtD
Vinorelbine—Skin disorder—Zoledronate—osteoporosis	0.000302	0.000853	CcSEcCtD
Vinorelbine—Pruritus—Calcitriol—osteoporosis	0.000301	0.00085	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.0003	0.000849	CcSEcCtD
Vinorelbine—Diarrhoea—Raloxifene—osteoporosis	0.0003	0.000849	CcSEcCtD
Vinorelbine—Dizziness—Estropipate—osteoporosis	0.0003	0.000847	CcSEcCtD
Vinorelbine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000299	0.000846	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—CCT2—osteoporosis	0.000298	0.00099	CbGpPWpGaD
Vinorelbine—Alopecia—Estradiol—osteoporosis	0.000298	0.000842	CcSEcCtD
Vinorelbine—Infection—Conjugated Estrogens—osteoporosis	0.000297	0.000841	CcSEcCtD
Vinorelbine—Diarrhoea—Ibandronate—osteoporosis	0.000297	0.00084	CcSEcCtD
Vinorelbine—Anorexia—Zoledronate—osteoporosis	0.000296	0.000838	CcSEcCtD
Vinorelbine—Decreased appetite—Pamidronate—osteoporosis	0.000296	0.000836	CcSEcCtD
Vinorelbine—Dizziness—Alendronate—osteoporosis	0.000295	0.000834	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000294	0.000831	CcSEcCtD
Vinorelbine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000294	0.00083	CcSEcCtD
Vinorelbine—Erythema—Estradiol—osteoporosis	0.000293	0.00083	CcSEcCtD
Vinorelbine—Malnutrition—Estradiol—osteoporosis	0.000293	0.00083	CcSEcCtD
Vinorelbine—Fatigue—Pamidronate—osteoporosis	0.000293	0.000829	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Risedronate—osteoporosis	0.000293	0.000827	CcSEcCtD
Vinorelbine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000292	0.000826	CcSEcCtD
Vinorelbine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000292	0.000825	CcSEcCtD
Vinorelbine—Constipation—Pamidronate—osteoporosis	0.000291	0.000823	CcSEcCtD
Vinorelbine—Pain—Pamidronate—osteoporosis	0.000291	0.000823	CcSEcCtD
Vinorelbine—Diarrhoea—Calcitriol—osteoporosis	0.000291	0.000822	CcSEcCtD
Vinorelbine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000291	0.000822	CcSEcCtD
Vinorelbine—Hypotension—Zoledronate—osteoporosis	0.00029	0.000821	CcSEcCtD
Vinorelbine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00029	0.00082	CcSEcCtD
Vinorelbine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00029	0.00082	CcSEcCtD
Vinorelbine—Dizziness—Raloxifene—osteoporosis	0.00029	0.00082	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—CCT2—osteoporosis	0.000289	0.000958	CbGpPWpGaD
Vinorelbine—Vomiting—Estropipate—osteoporosis	0.000288	0.000814	CcSEcCtD
Vinorelbine—Dizziness—Ibandronate—osteoporosis	0.000287	0.000812	CcSEcCtD
Vinorelbine—Rash—Estropipate—osteoporosis	0.000286	0.000807	CcSEcCtD
Vinorelbine—Dermatitis—Estropipate—osteoporosis	0.000285	0.000807	CcSEcCtD
Vinorelbine—Anorexia—Conjugated Estrogens—osteoporosis	0.000285	0.000807	CcSEcCtD
Vinorelbine—Urticaria—Risedronate—osteoporosis	0.000284	0.000804	CcSEcCtD
Vinorelbine—Back pain—Estradiol—osteoporosis	0.000284	0.000803	CcSEcCtD
Vinorelbine—Headache—Estropipate—osteoporosis	0.000284	0.000802	CcSEcCtD
Vinorelbine—Vomiting—Alendronate—osteoporosis	0.000284	0.000802	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000283	0.000801	CcSEcCtD
Vinorelbine—Body temperature increased—Risedronate—osteoporosis	0.000283	0.0008	CcSEcCtD
Vinorelbine—Abdominal pain—Risedronate—osteoporosis	0.000283	0.0008	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—CCT2—osteoporosis	0.000282	0.000937	CbGpPWpGaD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000282	0.000934	CbGpPWpGaD
Vinorelbine—Rash—Alendronate—osteoporosis	0.000281	0.000795	CcSEcCtD
Vinorelbine—Dermatitis—Alendronate—osteoporosis	0.000281	0.000794	CcSEcCtD
Vinorelbine—Feeling abnormal—Pamidronate—osteoporosis	0.00028	0.000793	CcSEcCtD
Vinorelbine—Hypotension—Conjugated Estrogens—osteoporosis	0.00028	0.000791	CcSEcCtD
Vinorelbine—Headache—Alendronate—osteoporosis	0.000279	0.00079	CcSEcCtD
Vinorelbine—Paraesthesia—Zoledronate—osteoporosis	0.000279	0.000789	CcSEcCtD
Vinorelbine—Vomiting—Raloxifene—osteoporosis	0.000279	0.000789	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000278	0.000787	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000278	0.000922	CbGpPWpGaD
Vinorelbine—Dyspnoea—Zoledronate—osteoporosis	0.000277	0.000783	CcSEcCtD
Vinorelbine—Rash—Raloxifene—osteoporosis	0.000277	0.000782	CcSEcCtD
Vinorelbine—Dermatitis—Raloxifene—osteoporosis	0.000276	0.000781	CcSEcCtD
Vinorelbine—Vomiting—Ibandronate—osteoporosis	0.000276	0.000781	CcSEcCtD
Vinorelbine—Headache—Raloxifene—osteoporosis	0.000275	0.000777	CcSEcCtD
Vinorelbine—Rash—Ibandronate—osteoporosis	0.000274	0.000774	CcSEcCtD
Vinorelbine—Dermatitis—Ibandronate—osteoporosis	0.000274	0.000774	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000273	0.000771	CcSEcCtD
Vinorelbine—Ill-defined disorder—Estradiol—osteoporosis	0.000272	0.00077	CcSEcCtD
Vinorelbine—Headache—Ibandronate—osteoporosis	0.000272	0.000769	CcSEcCtD
Vinorelbine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00027	0.000765	CcSEcCtD
Vinorelbine—Vomiting—Calcitriol—osteoporosis	0.00027	0.000764	CcSEcCtD
Vinorelbine—Decreased appetite—Zoledronate—osteoporosis	0.00027	0.000764	CcSEcCtD
Vinorelbine—Nausea—Estropipate—osteoporosis	0.000269	0.000761	CcSEcCtD
Vinorelbine—Abdominal pain—Pamidronate—osteoporosis	0.000269	0.00076	CcSEcCtD
Vinorelbine—Body temperature increased—Pamidronate—osteoporosis	0.000269	0.00076	CcSEcCtD
Vinorelbine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000269	0.00076	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000268	0.000759	CcSEcCtD
Vinorelbine—Angioedema—Estradiol—osteoporosis	0.000268	0.000758	CcSEcCtD
Vinorelbine—Rash—Calcitriol—osteoporosis	0.000268	0.000758	CcSEcCtD
Vinorelbine—Fatigue—Zoledronate—osteoporosis	0.000268	0.000758	CcSEcCtD
Vinorelbine—Dermatitis—Calcitriol—osteoporosis	0.000268	0.000757	CcSEcCtD
Vinorelbine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000267	0.000754	CcSEcCtD
Vinorelbine—Headache—Calcitriol—osteoporosis	0.000266	0.000753	CcSEcCtD
Vinorelbine—Pain—Zoledronate—osteoporosis	0.000266	0.000751	CcSEcCtD
Vinorelbine—Constipation—Zoledronate—osteoporosis	0.000266	0.000751	CcSEcCtD
Vinorelbine—Nausea—Alendronate—osteoporosis	0.000265	0.000749	CcSEcCtD
Vinorelbine—Malaise—Estradiol—osteoporosis	0.000265	0.000748	CcSEcCtD
Vinorelbine—Hypersensitivity—Risedronate—osteoporosis	0.000264	0.000746	CcSEcCtD
Vinorelbine—Vertigo—Estradiol—osteoporosis	0.000264	0.000745	CcSEcCtD
Vinorelbine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000263	0.000745	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—TUBA1B—osteoporosis	0.000263	0.000871	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—TUBA1B—osteoporosis	0.000263	0.000871	CbGpPWpGaD
Vinorelbine—Nausea—Raloxifene—osteoporosis	0.000261	0.000737	CcSEcCtD
Vinorelbine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00026	0.000735	CcSEcCtD
Vinorelbine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00026	0.000734	CcSEcCtD
Vinorelbine—Palpitations—Estradiol—osteoporosis	0.000259	0.000733	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000258	0.00073	CcSEcCtD
Vinorelbine—Fatigue—Conjugated Estrogens—osteoporosis	0.000258	0.000729	CcSEcCtD
Vinorelbine—Nausea—Ibandronate—osteoporosis	0.000258	0.000729	CcSEcCtD
Vinorelbine—Asthenia—Risedronate—osteoporosis	0.000257	0.000726	CcSEcCtD
Vinorelbine—Feeling abnormal—Zoledronate—osteoporosis	0.000256	0.000724	CcSEcCtD
Vinorelbine—Cough—Estradiol—osteoporosis	0.000256	0.000724	CcSEcCtD
Vinorelbine—Constipation—Conjugated Estrogens—osteoporosis	0.000256	0.000724	CcSEcCtD
Vinorelbine—Pain—Conjugated Estrogens—osteoporosis	0.000256	0.000724	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000254	0.000719	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—CCT2—osteoporosis	0.000254	0.000841	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—TUBA1B—osteoporosis	0.000254	0.000841	CbGpPWpGaD
Vinorelbine—Hypertension—Estradiol—osteoporosis	0.000253	0.000716	CcSEcCtD
Vinorelbine—Pruritus—Risedronate—osteoporosis	0.000253	0.000716	CcSEcCtD
Vinorelbine—Nausea—Calcitriol—osteoporosis	0.000253	0.000714	CcSEcCtD
Vinorelbine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000251	0.00071	CcSEcCtD
Vinorelbine—Hypersensitivity—Pamidronate—osteoporosis	0.000251	0.000709	CcSEcCtD
Vinorelbine—Chest pain—Estradiol—osteoporosis	0.00025	0.000706	CcSEcCtD
Vinorelbine—Myalgia—Estradiol—osteoporosis	0.00025	0.000706	CcSEcCtD
Vinorelbine—Arthralgia—Estradiol—osteoporosis	0.00025	0.000706	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000248	0.000702	CcSEcCtD
Vinorelbine—Urticaria—Zoledronate—osteoporosis	0.000247	0.000698	CcSEcCtD
Vinorelbine—Discomfort—Estradiol—osteoporosis	0.000247	0.000698	CcSEcCtD
Vinorelbine—Abdominal pain—Zoledronate—osteoporosis	0.000246	0.000695	CcSEcCtD
Vinorelbine—Body temperature increased—Zoledronate—osteoporosis	0.000246	0.000695	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—TUBA1B—osteoporosis	0.000246	0.000815	CbGpPWpGaD
Vinorelbine—Diarrhoea—Risedronate—osteoporosis	0.000245	0.000692	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000245	0.000692	CcSEcCtD
Vinorelbine—Asthenia—Pamidronate—osteoporosis	0.000244	0.00069	CcSEcCtD
Vinorelbine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000243	0.000686	CcSEcCtD
Vinorelbine—Pruritus—Pamidronate—osteoporosis	0.000241	0.000681	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—TUBA1B—osteoporosis	0.00024	0.000797	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Estradiol—osteoporosis	0.00024	0.000677	CcSEcCtD
Vinorelbine—Infection—Estradiol—osteoporosis	0.000238	0.000673	CcSEcCtD
Vinorelbine—Urticaria—Conjugated Estrogens—osteoporosis	0.000238	0.000672	CcSEcCtD
Vinorelbine—Dizziness—Risedronate—osteoporosis	0.000237	0.000669	CcSEcCtD
Vinorelbine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000237	0.000669	CcSEcCtD
Vinorelbine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000237	0.000669	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000236	0.000782	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000236	0.000782	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Estradiol—osteoporosis	0.000235	0.000664	CcSEcCtD
Vinorelbine—Tachycardia—Estradiol—osteoporosis	0.000234	0.000661	CcSEcCtD
Vinorelbine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000233	0.00066	CcSEcCtD
Vinorelbine—Diarrhoea—Pamidronate—osteoporosis	0.000233	0.000658	CcSEcCtD
Vinorelbine—Skin disorder—Estradiol—osteoporosis	0.000233	0.000658	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—CCT2—osteoporosis	0.000232	0.00077	CbGpPWpGaD
Vinorelbine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000232	0.000769	CbGpPWpGaD
Vinorelbine—Rash—Ethinyl Estradiol—osteoporosis	0.000231	0.000654	CcSEcCtD
Vinorelbine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000231	0.000654	CcSEcCtD
Vinorelbine—Headache—Ethinyl Estradiol—osteoporosis	0.00023	0.00065	CcSEcCtD
Vinorelbine—Hypersensitivity—Zoledronate—osteoporosis	0.000229	0.000647	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000228	0.000758	CbGpPWpGaD
Vinorelbine—Vomiting—Risedronate—osteoporosis	0.000228	0.000643	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000228	0.000755	CbGpPWpGaD
Vinorelbine—Rash—Risedronate—osteoporosis	0.000226	0.000638	CcSEcCtD
Vinorelbine—Dermatitis—Risedronate—osteoporosis	0.000225	0.000637	CcSEcCtD
Vinorelbine—Dizziness—Pamidronate—osteoporosis	0.000225	0.000636	CcSEcCtD
Vinorelbine—Headache—Risedronate—osteoporosis	0.000224	0.000634	CcSEcCtD
Vinorelbine—Asthenia—Zoledronate—osteoporosis	0.000223	0.00063	CcSEcCtD
Vinorelbine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000221	0.000623	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00022	0.000731	CbGpPWpGaD
Vinorelbine—Pruritus—Zoledronate—osteoporosis	0.00022	0.000622	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000218	0.000617	CcSEcCtD
Vinorelbine—Nausea—Ethinyl Estradiol—osteoporosis	0.000218	0.000616	CcSEcCtD
Vinorelbine—Vomiting—Pamidronate—osteoporosis	0.000216	0.000612	CcSEcCtD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000216	0.000717	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—TUBA1B—osteoporosis	0.000216	0.000715	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000215	0.000715	CbGpPWpGaD
Vinorelbine—Paraesthesia—Estradiol—osteoporosis	0.000215	0.000608	CcSEcCtD
Vinorelbine—Asthenia—Conjugated Estrogens—osteoporosis	0.000215	0.000607	CcSEcCtD
Vinorelbine—Rash—Pamidronate—osteoporosis	0.000215	0.000607	CcSEcCtD
Vinorelbine—Dermatitis—Pamidronate—osteoporosis	0.000214	0.000606	CcSEcCtD
Vinorelbine—Dyspnoea—Estradiol—osteoporosis	0.000214	0.000604	CcSEcCtD
Vinorelbine—Headache—Pamidronate—osteoporosis	0.000213	0.000603	CcSEcCtD
Vinorelbine—Diarrhoea—Zoledronate—osteoporosis	0.000213	0.000601	CcSEcCtD
Vinorelbine—Nausea—Risedronate—osteoporosis	0.000213	0.000601	CcSEcCtD
Vinorelbine—Pruritus—Conjugated Estrogens—osteoporosis	0.000212	0.000599	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—RPL24—osteoporosis	0.00021	0.000697	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—RPL24—osteoporosis	0.00021	0.000697	CbGpPWpGaD
Vinorelbine—Decreased appetite—Estradiol—osteoporosis	0.000208	0.000589	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000207	0.000585	CcSEcCtD
Vinorelbine—Fatigue—Estradiol—osteoporosis	0.000207	0.000584	CcSEcCtD
Vinorelbine—Dizziness—Zoledronate—osteoporosis	0.000206	0.000581	CcSEcCtD
Vinorelbine—Pain—Estradiol—osteoporosis	0.000205	0.000579	CcSEcCtD
Vinorelbine—Constipation—Estradiol—osteoporosis	0.000205	0.000579	CcSEcCtD
Vinorelbine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000205	0.000579	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—RPL24—osteoporosis	0.000203	0.000673	CbGpPWpGaD
Vinorelbine—Nausea—Pamidronate—osteoporosis	0.000202	0.000571	CcSEcCtD
Vinorelbine—Dizziness—Conjugated Estrogens—osteoporosis	0.000198	0.000559	CcSEcCtD
Vinorelbine—Vomiting—Zoledronate—osteoporosis	0.000198	0.000559	CcSEcCtD
Vinorelbine—Feeling abnormal—Estradiol—osteoporosis	0.000197	0.000558	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—TUBA1B—osteoporosis	0.000197	0.000654	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—RPL24—osteoporosis	0.000196	0.000652	CbGpPWpGaD
Vinorelbine—Rash—Zoledronate—osteoporosis	0.000196	0.000554	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Estradiol—osteoporosis	0.000196	0.000554	CcSEcCtD
Vinorelbine—Dermatitis—Zoledronate—osteoporosis	0.000196	0.000554	CcSEcCtD
Vinorelbine—Headache—Zoledronate—osteoporosis	0.000195	0.00055	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000193	0.000642	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—RPL24—osteoporosis	0.000192	0.000637	CbGpPWpGaD
Vinorelbine—Vomiting—Conjugated Estrogens—osteoporosis	0.00019	0.000538	CcSEcCtD
Vinorelbine—Urticaria—Estradiol—osteoporosis	0.00019	0.000538	CcSEcCtD
Vinorelbine—Abdominal pain—Estradiol—osteoporosis	0.000189	0.000535	CcSEcCtD
Vinorelbine—Body temperature increased—Estradiol—osteoporosis	0.000189	0.000535	CcSEcCtD
Vinorelbine—Rash—Conjugated Estrogens—osteoporosis	0.000189	0.000533	CcSEcCtD
Vinorelbine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000189	0.000533	CcSEcCtD
Vinorelbine—Headache—Conjugated Estrogens—osteoporosis	0.000187	0.00053	CcSEcCtD
Vinorelbine—Nausea—Zoledronate—osteoporosis	0.000185	0.000522	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—TLN1—osteoporosis	0.000185	0.000612	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—TLN1—osteoporosis	0.000185	0.000612	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000184	0.000611	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000182	0.000604	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000182	0.000603	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—TLN1—osteoporosis	0.000178	0.000591	CbGpPWpGaD
Vinorelbine—Nausea—Conjugated Estrogens—osteoporosis	0.000178	0.000503	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—REN—osteoporosis	0.000177	0.000589	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—REN—osteoporosis	0.000177	0.000589	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000177	0.000587	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Estradiol—osteoporosis	0.000176	0.000499	CcSEcCtD
Vinorelbine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000174	0.000576	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—TLN1—osteoporosis	0.000173	0.000573	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—RPL24—osteoporosis	0.000172	0.000572	CbGpPWpGaD
Vinorelbine—Asthenia—Estradiol—osteoporosis	0.000172	0.000486	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—REN—osteoporosis	0.000171	0.000568	CbGpPWpGaD
Vinorelbine—Pruritus—Estradiol—osteoporosis	0.000169	0.000479	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—TLN1—osteoporosis	0.000169	0.00056	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—REN—osteoporosis	0.000166	0.00055	CbGpPWpGaD
Vinorelbine—Diarrhoea—Estradiol—osteoporosis	0.000164	0.000463	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—REN—osteoporosis	0.000162	0.000538	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000161	0.000534	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000161	0.000534	CbGpPWpGaD
Vinorelbine—Dizziness—Estradiol—osteoporosis	0.000158	0.000448	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—RPL24—osteoporosis	0.000158	0.000523	CbGpPWpGaD
Vinorelbine—Vomiting—Estradiol—osteoporosis	0.000152	0.000431	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—TLN1—osteoporosis	0.000152	0.000503	CbGpPWpGaD
Vinorelbine—Rash—Estradiol—osteoporosis	0.000151	0.000427	CcSEcCtD
Vinorelbine—Dermatitis—Estradiol—osteoporosis	0.000151	0.000427	CcSEcCtD
Vinorelbine—Headache—Estradiol—osteoporosis	0.00015	0.000424	CcSEcCtD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000149	0.000495	CbGpPWpGaD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000148	0.000491	CbGpPWpGaD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000146	0.000484	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—REN—osteoporosis	0.000146	0.000483	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—PSMA2—osteoporosis	0.000144	0.000478	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—PSMA5—osteoporosis	0.000144	0.000478	CbGpPWpGaD
Vinorelbine—Nausea—Estradiol—osteoporosis	0.000142	0.000402	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—TLN1—osteoporosis	0.000139	0.00046	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000133	0.000443	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000133	0.000443	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—REN—osteoporosis	0.000133	0.000442	CbGpPWpGaD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000133	0.000442	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000122	0.000405	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000122	0.000405	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000121	0.000402	CbGpPWpGaD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00012	0.000398	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.00012	0.000397	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.00012	0.000397	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—PSMA5—osteoporosis	0.000119	0.000396	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—PSMA2—osteoporosis	0.000119	0.000396	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—ACE—osteoporosis	0.000111	0.000367	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—ACE—osteoporosis	0.000111	0.000367	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PSMA2—osteoporosis	0.000109	0.000362	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PSMA5—osteoporosis	0.000109	0.000362	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—ACE—osteoporosis	0.000107	0.000355	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—ACE—osteoporosis	0.000104	0.000344	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000102	0.000338	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—ACE—osteoporosis	0.000101	0.000336	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.67e-05	0.000321	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	9.62e-05	0.000319	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.55e-05	0.000317	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—ACE—osteoporosis	9.09e-05	0.000302	CbGpPWpGaD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.89e-05	0.000295	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.84e-05	0.000293	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.84e-05	0.000293	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.54e-05	0.000283	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—ACE—osteoporosis	8.32e-05	0.000276	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.27e-05	0.000274	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.08e-05	0.000268	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	7.93e-05	0.000263	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.84e-05	0.00026	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.82e-05	0.000259	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.26e-05	0.000241	CbGpPWpGaD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.21e-05	0.000239	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—LEP—osteoporosis	6.88e-05	0.000228	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—LEP—osteoporosis	6.88e-05	0.000228	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	6.85e-05	0.000227	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—LEP—osteoporosis	6.64e-05	0.00022	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.64e-05	0.00022	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—LEP—osteoporosis	6.43e-05	0.000213	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	6.41e-05	0.000213	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	6.37e-05	0.000211	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—LEP—osteoporosis	6.29e-05	0.000209	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	6.28e-05	0.000208	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—POMC—osteoporosis	5.91e-05	0.000196	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—POMC—osteoporosis	5.91e-05	0.000196	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.81e-05	0.000193	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—POMC—osteoporosis	5.71e-05	0.000189	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—IGF1—osteoporosis	5.68e-05	0.000189	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—IGF1—osteoporosis	5.68e-05	0.000189	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—LEP—osteoporosis	5.65e-05	0.000187	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL1B—osteoporosis	5.62e-05	0.000186	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—POMC—osteoporosis	5.53e-05	0.000183	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGF1—osteoporosis	5.49e-05	0.000182	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—POMC—osteoporosis	5.4e-05	0.000179	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.38e-05	0.000178	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—IGF1—osteoporosis	5.32e-05	0.000176	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—IGF1—osteoporosis	5.2e-05	0.000172	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—LEP—osteoporosis	5.16e-05	0.000171	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—POMC—osteoporosis	4.85e-05	0.000161	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.71e-05	0.000156	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—IGF1—osteoporosis	4.67e-05	0.000155	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—osteoporosis	4.54e-05	0.000151	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—POMC—osteoporosis	4.44e-05	0.000147	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.37e-05	0.000145	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGF1—osteoporosis	4.27e-05	0.000142	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.17e-05	0.000138	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.15e-05	0.000138	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.11e-05	0.000136	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—osteoporosis	4.08e-05	0.000135	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—osteoporosis	4.06e-05	0.000135	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FDPS—osteoporosis	3.83e-05	0.000127	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PKM—osteoporosis	3.83e-05	0.000127	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—POMC—osteoporosis	3.83e-05	0.000127	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—osteoporosis	3.76e-05	0.000125	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPD2—osteoporosis	3.63e-05	0.000121	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PGLS—osteoporosis	3.63e-05	0.000121	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PKM—osteoporosis	3.61e-05	0.00012	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FDPS—osteoporosis	3.61e-05	0.00012	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.59e-05	0.000119	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—osteoporosis	3.44e-05	0.000114	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PGLS—osteoporosis	3.42e-05	0.000114	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPD2—osteoporosis	3.42e-05	0.000114	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—osteoporosis	3.36e-05	0.000112	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PNP—osteoporosis	3.32e-05	0.00011	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ATIC—osteoporosis	3.32e-05	0.00011	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PNP—osteoporosis	3.13e-05	0.000104	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ATIC—osteoporosis	3.13e-05	0.000104	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—osteoporosis	3.08e-05	0.000102	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA2—osteoporosis	2.83e-05	9.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—OXCT1—osteoporosis	2.83e-05	9.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MGLL—osteoporosis	2.75e-05	9.14e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—OXCT1—osteoporosis	2.66e-05	8.83e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA2—osteoporosis	2.66e-05	8.83e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MGLL—osteoporosis	2.59e-05	8.61e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.5e-05	8.31e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PKM—osteoporosis	2.36e-05	7.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FDPS—osteoporosis	2.36e-05	7.83e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—IDH2—osteoporosis	2.34e-05	7.77e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PGLS—osteoporosis	2.24e-05	7.43e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPD2—osteoporosis	2.24e-05	7.43e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—IDH2—osteoporosis	2.21e-05	7.32e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP27A1—osteoporosis	2.2e-05	7.3e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.16e-05	7.17e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.15e-05	7.15e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ACP5—osteoporosis	2.14e-05	7.1e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.07e-05	6.88e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PNP—osteoporosis	2.05e-05	6.79e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ATIC—osteoporosis	2.05e-05	6.79e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ACP5—osteoporosis	2.02e-05	6.69e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.02e-05	6.69e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.01e-05	6.68e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TPI1—osteoporosis	1.99e-05	6.6e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TPI1—osteoporosis	1.88e-05	6.22e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—P4HB—osteoporosis	1.87e-05	6.21e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GAPDH—osteoporosis	1.84e-05	6.1e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—RAP1A—osteoporosis	1.79e-05	5.94e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—P4HB—osteoporosis	1.76e-05	5.85e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA2—osteoporosis	1.74e-05	5.78e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.74e-05	5.78e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.73e-05	5.74e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MGLL—osteoporosis	1.7e-05	5.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.69e-05	5.59e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ENO1—osteoporosis	1.45e-05	4.8e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—IDH2—osteoporosis	1.44e-05	4.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSMA5—osteoporosis	1.43e-05	4.73e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSMA2—osteoporosis	1.43e-05	4.73e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ENO1—osteoporosis	1.36e-05	4.52e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.36e-05	4.5e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.34e-05	4.46e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.34e-05	4.46e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ACP5—osteoporosis	1.32e-05	4.38e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TPI1—osteoporosis	1.23e-05	4.07e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.16e-05	3.84e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—P4HB—osteoporosis	1.15e-05	3.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.13e-05	3.76e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.1e-05	3.66e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.09e-05	3.62e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ADCY5—osteoporosis	9.45e-06	3.13e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPX1—osteoporosis	9.42e-06	3.12e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ENO1—osteoporosis	8.91e-06	2.96e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ADCY5—osteoporosis	8.9e-06	2.95e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPX1—osteoporosis	8.87e-06	2.94e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSMA5—osteoporosis	8.78e-06	2.91e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSMA2—osteoporosis	8.78e-06	2.91e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—osteoporosis	8.69e-06	2.88e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—osteoporosis	8.19e-06	2.72e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.12e-06	2.36e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—POMC—osteoporosis	6.95e-06	2.31e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—POMC—osteoporosis	6.55e-06	2.17e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ADCY5—osteoporosis	5.82e-06	1.93e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPX1—osteoporosis	5.8e-06	1.92e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—osteoporosis	5.35e-06	1.78e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—POMC—osteoporosis	4.28e-06	1.42e-05	CbGpPWpGaD
